NEW YORK (GenomeWeb News) – Shares of CombiMatrix closed at a 52-week high of $13.31 on Wednesday.
Over the past two weeks, shares of the Mukilteo, Wash.-based microarray manufacturer and molecular diagnostics firm have climbed around 20 percent. Year to date, the company’s stock is up nearly 80 percent.
Last week, CombiMatrix reported that its second-quarter revenues jumped 55 percent to $2.1 million, driven by diagnostic services revenue.
A year ago, the firm completed its split from former parent company Acacia Research as part of an effort to focus on the molecular diagnostics market.